Episode Details

Is Germany’s cannabis policy about to run into European Union law? That’s the big question this week as global cannabis markets face major policy debates and expansion moves.This is TDR Cannabis in Five, presented by Prohibition Partners — the global data, events, and B2B cannabis intelligence firm. In this episode, the focus shifts to the biggest international headlines shaping cannabis today.Germany leads the conversation with a proposed telemedicine ban for medical cannabis that experts say could violate EU protections on patient rights. Canadian retailer High Tide is battling pushback as it tries to expand into Germany, while Aurora Cannabis is betting big with a major cultivation expansion. In the UK, Curaleaf is building partnerships to educate doctors and widen patient access.Across Latin America, Uruguay has integrated CBD into its public healthcare system, and Brazilian scientists have identified CBD in a native shrub species, expanding research potential. In Asia-Pacific, Sri Lanka has signaled support for cannabis cultivation and foreign investment, while Thailand faces criticism over its cannabis tourism image. Australia’s pharmacists are also calling for a larger role in medical cannabis dispensing.Finally, Israeli operator InterCure is moving into the U.S. market with a new acquisition, signaling international consolidation as optimism around rescheduling builds.#CannabisNews #CannabisIndustry #GlobalCannabis #GermanyCannabis #AuroraCannabis #HighTide #Curaleaf #UruguayCBD #CannabisPolicy #CannabisReschedulingWant to see last week's recap?   • Cannabis Industry Fights for Billions in R...  Want to see more Cannabis Reform videos?   • Trump Holds All the Cards on Cannabis Resc...     • Trump DOJ Splits on Marijuana Gun Ban | TD...     • Congress Exposes Chinese Cannabis Cartel N...     • Trump’s Drug Czar Pick: Cannabis a Biparti...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:

Listen Now